Sushant K. Kachhap

2.6k total citations
48 papers, 1.9k citations indexed

About

Sushant K. Kachhap is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Sushant K. Kachhap has authored 48 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 12 papers in Oncology. Recurrent topics in Sushant K. Kachhap's work include Prostate Cancer Treatment and Research (11 papers), Histone Deacetylase Inhibitors Research (10 papers) and Ubiquitin and proteasome pathways (9 papers). Sushant K. Kachhap is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Histone Deacetylase Inhibitors Research (10 papers) and Ubiquitin and proteasome pathways (9 papers). Sushant K. Kachhap collaborates with scholars based in United States, Netherlands and India. Sushant K. Kachhap's co-authors include Michael A. Carducci, David Z. Qian, Роберто Пили, Peter Atadja, Spencer J. Collis, Henk M.W. Verheul, Shabana Shabbeer, Janet Mendonca, Hans J. Hammers and Madeleine S.Q. Kortenhorst and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Sushant K. Kachhap

46 papers receiving 1.9k citations

Peers

Sushant K. Kachhap
Chandra Bartholomeusz United States
Xisong Ke China
Shou‐Ching Tang United States
Ying Hu China
Kyung Song United States
Sven A. Lang Germany
Chandra Bartholomeusz United States
Sushant K. Kachhap
Citations per year, relative to Sushant K. Kachhap Sushant K. Kachhap (= 1×) peers Chandra Bartholomeusz

Countries citing papers authored by Sushant K. Kachhap

Since Specialization
Citations

This map shows the geographic impact of Sushant K. Kachhap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sushant K. Kachhap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sushant K. Kachhap more than expected).

Fields of papers citing papers by Sushant K. Kachhap

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sushant K. Kachhap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sushant K. Kachhap. The network helps show where Sushant K. Kachhap may publish in the future.

Co-authorship network of co-authors of Sushant K. Kachhap

This figure shows the co-authorship network connecting the top 25 collaborators of Sushant K. Kachhap. A scholar is included among the top collaborators of Sushant K. Kachhap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sushant K. Kachhap. Sushant K. Kachhap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paller, Channing J., Lin Wang, Wei Fu, et al.. (2023). Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer. Cancer Research Communications. 3(2). 338–346. 7 indexed citations
2.
Kumar, Rajendra, Laura A. Sena, Samuel R. Denmeade, & Sushant K. Kachhap. (2022). The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implications. Nature Reviews Urology. 20(5). 265–278. 31 indexed citations
3.
Markowski, Mark C., Sushant K. Kachhap, Angelo M. De Marzo, et al.. (2021). Molecular and Clinical Characterization of Patients With Metastatic Castration Resistant Prostate Cancer Achieving Deep Responses to Bipolar Androgen Therapy. Clinical Genitourinary Cancer. 20(2). 97–101. 17 indexed citations
4.
Markowski, Mark C., Eugene Shenderov, Mario A. Eisenberger, et al.. (2020). Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer. The Prostate. 80(5). 407–411. 25 indexed citations
5.
Geng, Hao, Changhui Xue, Janet Mendonca, et al.. (2018). Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen/AR-targeted therapy. Nature Communications. 9(1). 4972–4972. 54 indexed citations
6.
Barakat, David J., Janet Mendonca, Theresa J. Barberi, et al.. (2016). C/EBPβ regulates sensitivity to bortezomib in prostate cancer cells by inducing REDD1 and autophagosome–lysosome fusion. Cancer Letters. 375(1). 152–161. 31 indexed citations
7.
Wissing, Michel D., Eunice Kim, Klaus Piontek, et al.. (2014). Small-molecule screening of PC3 prostate cancer cells identifies tilorone dihydrochloride to selectively inhibit cell growth based on cyclin-dependent kinase 5 expression. Oncology Reports. 32(1). 419–424. 16 indexed citations
8.
Fu, Chenglai, Anita van der Zwan, Wayne C. H. Wang, et al.. (2013). Screening assay for blood vessel maturation inhibitors. Biochemical and Biophysical Research Communications. 438(2). 364–369. 6 indexed citations
9.
Kortenhorst, Madeleine S.Q., Michel D. Wissing, Ronald Rodríguez, et al.. (2013). Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors. Epigenetics. 8(9). 907–920. 30 indexed citations
10.
Isaacs, John T., Lizamma Antony, Susan L. Dalrymple, et al.. (2012). Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer Microenvironment. Cancer Research. 73(4). 1386–1399. 89 indexed citations
11.
Gündüz, Mehmet, Esra Gündüz, Levent Beder, et al.. (2012). Metastasis: Genetics, Mechanism, and Diagnostic and Therapeutic Strategies. Journal of Oncology. 2012. 1–2. 2 indexed citations
12.
Kachhap, Sushant K., Venkateshwar G. Keshamouni, David Z. Qian, & Aditi Chatterjee. (2011). Cigarette Smoke and Cancer. Journal of Oncology. 2011. 1–2. 2 indexed citations
13.
Kachhap, Sushant K., Spencer J. Collis, Madeleine S.Q. Kortenhorst, et al.. (2010). Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor. PLoS ONE. 5(6). e11208–e11208. 134 indexed citations
14.
Shabbeer, Shabana, Ravi Anchoori, Sushant K. Kachhap, et al.. (2009). Fenugreek: A naturally occurring edible spice as an anticancer agent. Cancer Biology & Therapy. 8(3). 272–278. 81 indexed citations
15.
Shabbeer, Shabana, Madeleine S.Q. Kortenhorst, Sushant K. Kachhap, et al.. (2007). Multiple Molecular pathways explain the anti‐proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo. The Prostate. 67(10). 1099–1110. 67 indexed citations
16.
Kachhap, Sushant K., Dennis Faith, David Z. Qian, et al.. (2007). The N-Myc Down Regulated Gene1 (NDRG1) Is a Rab4a Effector Involved in Vesicular Recycling of E-Cadherin. PLoS ONE. 2(9). e844–e844. 99 indexed citations
17.
Kachhap, Sushant K. & Keshav K. Singh. (2004). Mitochondrial inhibition of uracil-DNA glycosylase is not mutagenic.. Molecular Cancer. 3(1). 32–32. 6 indexed citations
18.
Kachhap, Sushant K., et al.. (2001). Effect of ω-3 Fatty Acid (Docosahexanoic Acid) on BRCA1 Gene Expression and Growth in MCF-7 Cell Line. Cancer Biotherapy and Radiopharmaceuticals. 16(3). 257–263. 12 indexed citations
19.
Kachhap, Sushant K., et al.. (2001). REDUCED EXPRESSION OF THE BRCA1 GENE AND INCREASED CHROMOSOMAL INSTABILITY IN MCF‐7 CELL LINE. Cell Biology International. 25(6). 547–551. 7 indexed citations
20.
Kachhap, Sushant K., et al.. (2000). Effect of ω-6 polyunsaturated fatty acid (linoleic acid) on BRCA1 gene expression in MCF-7 cell line. Cancer Letters. 154(2). 115–120. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026